FR2068493A2 - - Google Patents

Info

Publication number
FR2068493A2
FR2068493A2 FR7029657A FR7029657A FR2068493A2 FR 2068493 A2 FR2068493 A2 FR 2068493A2 FR 7029657 A FR7029657 A FR 7029657A FR 7029657 A FR7029657 A FR 7029657A FR 2068493 A2 FR2068493 A2 FR 2068493A2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7029657A
Other languages
French (fr)
Other versions
FR2068493B2 (cg-RX-API-DMAC7.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19691941761 external-priority patent/DE1941761C3/de
Application filed by Schering AG filed Critical Schering AG
Publication of FR2068493A2 publication Critical patent/FR2068493A2/fr
Application granted granted Critical
Publication of FR2068493B2 publication Critical patent/FR2068493B2/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C19/00Dental auxiliary appliances
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03BAPPARATUS OR ARRANGEMENTS FOR TAKING PHOTOGRAPHS OR FOR PROJECTING OR VIEWING THEM; APPARATUS OR ARRANGEMENTS EMPLOYING ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ACCESSORIES THEREFOR
    • G03B17/00Details of cameras or camera bodies; Accessories therefor
    • G03B17/02Bodies

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dentistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
FR7029657A 1969-08-13 1970-08-12 Expired FR2068493B2 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19691941575 DE1941575A1 (de) 1969-08-13 1969-08-13 Neue Nitrofurylpyrimidinderivate
DE19691941761 DE1941761C3 (de) 1969-08-16 2-(Thienyl-3 '-amino) -1.3-diazacyclopentene und Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
FR2068493A2 true FR2068493A2 (cg-RX-API-DMAC7.html) 1971-08-27
FR2068493B2 FR2068493B2 (cg-RX-API-DMAC7.html) 1973-12-21

Family

ID=25757797

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7029657A Expired FR2068493B2 (cg-RX-API-DMAC7.html) 1969-08-13 1970-08-12
FR707030143A Expired FR2068505B1 (cg-RX-API-DMAC7.html) 1969-08-13 1970-08-17

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR707030143A Expired FR2068505B1 (cg-RX-API-DMAC7.html) 1969-08-13 1970-08-17

Country Status (10)

Country Link
US (2) US3758476A (cg-RX-API-DMAC7.html)
AT (3) AT304535B (cg-RX-API-DMAC7.html)
BE (2) BE754935A (cg-RX-API-DMAC7.html)
CA (1) CA1011738A (cg-RX-API-DMAC7.html)
CH (4) CH554894A (cg-RX-API-DMAC7.html)
DE (1) DE1941575A1 (cg-RX-API-DMAC7.html)
FR (2) FR2068493B2 (cg-RX-API-DMAC7.html)
GB (2) GB1324646A (cg-RX-API-DMAC7.html)
NL (2) NL164859C (cg-RX-API-DMAC7.html)
SE (1) SE368406B (cg-RX-API-DMAC7.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036972A (en) * 1973-02-23 1977-07-19 Boehringer Ingelheim Gmbh 2-(N-thienylmethyl-phenylamino)-imidazolines-(2) and salts thereof
DE2308883C3 (de) * 1973-02-23 1978-05-24 C.H. Boehringer Sohn, 6507 Ingelheim 2-Phenylamino-thienylmethyl-imidazoline-(2), Verfahren zur Herstellung derselben und diese enthaltene Arzneimittel
US3919225A (en) * 1974-04-26 1975-11-11 Universal Oil Prod Co Preparation of N-vinyl substituted amidines
US3919231A (en) * 1974-06-17 1975-11-11 Morton Norwich Products Inc Series of 5-aryl-2-furamidines
US3970648A (en) * 1974-09-06 1976-07-20 Diamond Shamrock Corporation 2-[2-(5-Nitro-2-furyl)vinyl]-4-(anilino)quinazolines
US4379926A (en) * 1978-05-08 1983-04-12 Ayerst, Mckenna & Harrison Ltd. 1,4,5,6-Tetrahydropyrimidine derivatives
DE3071229D1 (en) * 1979-08-23 1985-12-19 Beecham Group Plc Anti-diarrhoea veterinary composition
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
DE10224892A1 (de) 2002-06-04 2003-12-18 Aventis Pharma Gmbh Substituierte Thiophene, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US7049333B2 (en) * 2002-06-04 2006-05-23 Sanofi-Aventis Deutschland Gmbh Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10341240A1 (de) 2003-09-08 2005-04-07 Aventis Pharma Deutschland Gmbh Substituierte Thienoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US20080188499A1 (en) * 2004-09-23 2008-08-07 Ulysses Pharmaceutical Products Inc. Carbo- and Hetero-Cyclic Antibiotics and Use Thereof
BRPI0707308A2 (pt) * 2006-01-27 2011-05-03 Hoffmann La Roche uso de 2-imidazóis para o tratamento de distúrbios do snc
RU2009112496A (ru) * 2006-10-19 2010-11-27 Ф. Хоффманн-Ля Рош Аг (Ch) Аминометил-4-имидазолы
EP2076496B1 (en) * 2006-10-19 2010-03-31 F. Hoffmann-Roche AG Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors
KR101176700B1 (ko) * 2006-11-02 2012-08-23 에프. 호프만-라 로슈 아게 미량 아민 결합된 수용체의 조절자로서 치환된 2-이미다졸
CN101535298A (zh) * 2006-11-16 2009-09-16 弗·哈夫曼-拉罗切有限公司 取代的4-咪唑类化合物
WO2008071574A1 (en) * 2006-12-13 2008-06-19 F. Hoffmann-La Roche Ag Novel 2 -imidazoles as ligands for trace amine associated receptors (taar)
US20080146523A1 (en) * 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
UA98951C2 (ru) 2007-02-02 2012-07-10 Ф. Хоффманн-Ля Рош Аг 2-аминооксазолины и лекарственное средство, которое их содержит
KR101335845B1 (ko) 2007-02-15 2013-12-02 에프. 호프만-라 로슈 아게 Taar1 리간드로서의 2-아미노옥사졸린
CA2691082A1 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
CN101687811A (zh) * 2007-07-03 2010-03-31 弗·哈夫曼-拉罗切有限公司 4-咪唑啉类及其作为抗抑郁剂的应用
EP2183216A1 (en) * 2007-07-27 2010-05-12 F. Hoffmann-Roche AG 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands
WO2009016088A1 (en) * 2007-08-02 2009-02-05 F. Hoffmann-La Roche Ag The use of benzamide derivatives for the treatment of cns disorders
JP5341084B2 (ja) * 2007-08-03 2013-11-13 エフ.ホフマン−ラ ロシュ アーゲー Taar1リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体
AU2009273324A1 (en) * 2008-07-24 2010-01-28 F. Hoffmann-La Roche Ag 4,5-dihydro-oxazol-2-yl derivatives
US8242153B2 (en) * 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US20100311798A1 (en) * 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US8354441B2 (en) * 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
CA3013696C (en) 2016-03-17 2024-04-16 F. Hoffmann-La Roche Ag 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar
CN111686806B (zh) * 2020-05-29 2022-09-30 黑龙江大学 一种聚[2-(3-噻吩基)乙醇]/石墨相氮化碳复合可见光催化剂的制备方法及应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6808832A (cg-RX-API-DMAC7.html) * 1967-06-23 1968-12-24

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5402E (fr) * 1905-06-10 1906-03-27 Camille Durey Compteur automatique de mouvements d'organes chez les etres animés

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6808832A (cg-RX-API-DMAC7.html) * 1967-06-23 1968-12-24

Also Published As

Publication number Publication date
CH544116A (de) 1973-12-28
FR2068505A1 (cg-RX-API-DMAC7.html) 1971-08-27
FR2068505B1 (cg-RX-API-DMAC7.html) 1973-08-10
CA1011738A (en) 1977-06-07
NL7011933A (cg-RX-API-DMAC7.html) 1971-02-16
DE1941575A1 (de) 1971-03-04
DE1941761A1 (de) 1971-02-25
US3814758A (en) 1974-06-04
CH530415A (de) 1972-11-15
US3758476A (en) 1973-09-11
SE368406B (cg-RX-API-DMAC7.html) 1974-07-01
AT310157B (de) 1973-09-25
CH555358A (de) 1974-10-31
DE1941761B2 (de) 1976-01-08
AT310158B (de) 1973-09-25
BE754820R (fr) 1971-02-15
NL164859B (nl) 1980-09-15
GB1312133A (en) 1973-04-04
AT304535B (de) 1973-01-10
NL164859C (nl) 1981-02-16
CH554894A (de) 1974-10-15
GB1324646A (en) 1973-07-25
NL7011708A (cg-RX-API-DMAC7.html) 1971-02-18
BE754935A (fr) 1971-02-17
FR2068493B2 (cg-RX-API-DMAC7.html) 1973-12-21

Similar Documents

Publication Publication Date Title
FR2068505B1 (cg-RX-API-DMAC7.html)
AU465452B2 (cg-RX-API-DMAC7.html)
AU450150B2 (cg-RX-API-DMAC7.html)
AU442375B2 (cg-RX-API-DMAC7.html)
AU470301B1 (cg-RX-API-DMAC7.html)
AU5113869A (cg-RX-API-DMAC7.html)
AU442285B2 (cg-RX-API-DMAC7.html)
AU442380B2 (cg-RX-API-DMAC7.html)
AU442463B2 (cg-RX-API-DMAC7.html)
AU442357B2 (cg-RX-API-DMAC7.html)
AU442535B2 (cg-RX-API-DMAC7.html)
AU442538B2 (cg-RX-API-DMAC7.html)
AU442554B2 (cg-RX-API-DMAC7.html)
AU442322B2 (cg-RX-API-DMAC7.html)
AU470661B1 (cg-RX-API-DMAC7.html)
CS153773B1 (cg-RX-API-DMAC7.html)
AU4949169A (cg-RX-API-DMAC7.html)
CS153997B1 (cg-RX-API-DMAC7.html)
AU4540468A (cg-RX-API-DMAC7.html)
AU5598769A (cg-RX-API-DMAC7.html)
CS153685B1 (cg-RX-API-DMAC7.html)
AU5228269A (cg-RX-API-DMAC7.html)
AU5109569A (cg-RX-API-DMAC7.html)
CS154011B1 (cg-RX-API-DMAC7.html)
AU5066368A (cg-RX-API-DMAC7.html)